Literature DB >> 8103446

Ultradian oscillation in somatostatin binding in the arcuate nucleus of adult male rats.

G S Tannenbaum1, F Farhadi-Jou, A Beaudet.   

Abstract

The ultradian rhythm of GH secretion in the male rat is generated by the reciprocal cyclic release of somatostatin (SRIF) and GH-releasing factor (GRF) from the hypothalamus. We recently demonstrated the presence of high affinity [125I]SRIF-binding sites on a subpopulation of GRF-containing arcuate neurons in rat hypothalamus. In the present study, we tested the hypothesis that these binding sites undergo rhythmic fluctuations in parallel with those of GH. Adult male rats were killed at times associated with either a peak (1100 h) or trough (1300 h) period of the GH rhythm. The hypothalamus was serially sectioned from the retrochiasmatic nucleus, rostrally, to the mammillary recess of the third ventricle, caudally, and [125I]SRIF-binding sites were labeled in vitro using high resolution autoradiography. [125I]SRIF-labeled neuronal perikarya were counted at eight cross-sectional levels across the arcuate nucleus, and binding densities were quantitated over each of these cross-sectional surfaces using computer-assisted microdensitometry. Both the number of labeled cells and the density of [125I]SRIF binding varied as a function of the time of death. The average number of [125I]SRIF-labeled cells per 10-microns thick section was 2- to 3-fold higher in rats killed at 1100 h than in those killed at 1300 h. In addition, overall binding density levels were 65% higher in animals killed at the onset of a GH peak than in those killed at the time of a GH trough. Both of these effects were apparent throughout the rostrocaudal extent of the arcuate nucleus. In contrast, [125I]SRIF binding density in the cerebral cortex did not vary between 1100 and 1300 h. These results demonstrate an ultradian variation in SRIF binding to arcuate neurons in relation to the peaks and troughs of the GH rhythm. Such rhythmicity in SRIF receptors might underlie a temporal responsiveness of arcuate GRF neurons to endogenous SRIF and may be an important mechanism by which SRIF modulates the rhythmic release of hypothalamic GRF in generation of the ultradian rhythm of GH secretion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8103446     DOI: 10.1210/endo.133.3.8103446

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

Review 1.  Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.

Authors:  Monica Gola; Mauro Doga; Stefania Bonadonna; Gherardo Mazziotti; Pier Paolo Vescovi; Andrea Giustina
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

2.  A question of rhythm: recent advances in growth hormone research.

Authors:  J Hamilton
Journal:  CMAJ       Date:  1995-09-01       Impact factor: 8.262

3.  Neonatal monosodium glutamate treatment counteracts circadian arrhythmicity induced by phase shifts of the light-dark cycle in female and male Siberian hamsters.

Authors:  Brian J Prendergast; Kenneth G Onishi; Irving Zucker
Journal:  Brain Res       Date:  2013-05-20       Impact factor: 3.252

4.  Somatostatin in the rat periventricular nucleus: sex differences and effect of gonadal steroids.

Authors:  Harmke H Van Vugt; Bert J M Van de Heijning; Eline M Van der Beek
Journal:  Exp Brain Res       Date:  2008-04-18       Impact factor: 1.972

5.  Ultradian Secretion of Growth Hormone in Mice: Linking Physiology With Changes in Synapse Parameters Using Super-Resolution Microscopy.

Authors:  Klaudia Bednarz; Walaa Alshafie; Sarah Aufmkolk; Théotime Desserteaux; Pratap Singh Markam; Kai-Florian Storch; Thomas Stroh
Journal:  Front Neural Circuits       Date:  2020-05-25       Impact factor: 3.492

6.  Regulated resurfacing of a somatostatin receptor storage compartment fine-tunes pituitary secretion.

Authors:  Walaa Alshafie; Vincent Francis; Klaudia Bednarz; Yingzhou Edward Pan; Thomas Stroh; Peter S McPherson
Journal:  J Cell Biol       Date:  2020-01-06       Impact factor: 10.539

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.